THE INTERSECTION OF BRAIN SCIENCE & HUMAN POTENTIALPartner with us
neurofeedback.com
The newsletter
← Research & Evidence
Positive with limitationsPreregistered systematic review and random-effects meta-analysis

The effects of cognitive-behavioural therapy (CBT) on heart rate variability (HRV) in people with depression and/or anxiety disorders: A systematic review and meta-analysis

CBT was associated with improvement in some HRV measures, including HF-HRV, LF-HRV and SDNN, but not RMSSD or several other indices. The review did not test HRV biofeedback and does not yet establish HRV as a clinical treatment-response marker.

Alkout A, Husaini AHBE, Kadan A, Parlatini V, Cortese S, Bellato A.
International Journal of Psychophysiology · Publication date: 2026-10-09
Added to site: 2026-10-12
DOI: 10.1016/j.ijpsycho.2026.113495

Published online October 9, 2026. Added to Neurofeedback.com October 12, 2026 after abstract review.

Modalities
Heart-rate variability measurement, Cognitive-behavioural therapy
Clinical focus
Depression, Anxiety disorders, Physiological treatment markers
Population
Adults with depression and/or anxiety disorders receiving cognitive-behavioural therapy
Sample
12 studies identified; five randomized controlled trials were meta-analyzed and seven studies were narratively reviewed because calculable effects were unavailable
Intervention / method
Embase, PsycINFO, PubMed and Web of Science were searched under PROSPERO protocol CRD420251040957; pooled pre-post effects were estimated with Hedges' g
Comparator
Control conditions in the five randomized trials; the remaining seven studies contributed narrative evidence

Clinician summary

Compared with control, CBT produced significantly greater pre-post increases in HF-HRV, LF-HRV and SDNN across the meta-analyzed randomized trials. LF/HF ratio, RMSSD and triangular index did not change significantly. The authors describe the evidence as emerging and call for higher-quality studies before clinical biomarker use.

How to interpret the findings

Only five randomized trials supplied calculable effects, seven additional studies could not be pooled, and the abstract does not report pooled effect sizes, heterogeneity, risk-of-bias judgments, adverse events or publication-bias analyses. HRV index findings were mixed, and physiological change should not be treated as proof of symptom improvement or biofeedback efficacy.

Equipment and disclosures

This review evaluated HRV measurement around CBT, not HRV biofeedback or a specific device. The checked abstract does not support any vendor attribution.

Funding and competing-interest statements were not available in the checked abstract and PubMed record. The review was registered as PROSPERO CRD420251040957.

Related evidence

Compare findings from the same clinical area, including mixed results.

Abstract checked · Checked 2026-10-12

Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.